Biologicals

1.5(top 50%)

impact factor

1.9K(top 10%)

papers

30.7K(top 10%)

citations

67(top 10%)

h-index

1.7(top 50%)

impact factor

2.3K

all documents

32.3K

doc citations

95(top 10%)

g-index

Top Articles

#	Title	Journal	Year	Citations
1	Mechanism of Inactivation of Enveloped Viruses by the Biosurfactant Surfactin fromBacillus subtilis	Biologicals	1997	326
2	Vaccine instability in the cold chain: Mechanisms, analysis and formulation strategies	Biologicals	2014	296
3	Economic impact of BVDV infection in dairies	Biologicals	2003	276
4	Rapid and sensitive anthrone–sulfuric acid assay in microplate format to quantify carbohydrate in biopharmaceutical products: Method development and validation	Biologicals	2008	263
5	Determination of critical quality attributes for monoclonal antibodies using quality by design principles	Biologicals	2016	186
6	Gold, the Noble Metal and the Paradoxes of its Toxicology	Biologicals	1998	176
7	Antigenicity and Immunogenicity of Synthetic Peptides	Biologicals	2001	171
8	Factors effecting expression of vaccines in microalgae	Biologicals	2009	169
9	FluBlok, a next generation influenza vaccine manufactured in insect cells	Biologicals	2009	155
10	Pseudomonas aeruginosa biofilm: Potential therapeutic targets	Biologicals	2014	152
11	Transfusion-transmitted infectious diseases	Biologicals	2009	145
12	The challenge of indication extrapolation for infliximab biosimilars	Biologicals	2014	138
13	Highlights of mycoplasma research—An historical perspective	Biologicals	2010	133
14	Altenative Routes of Measles Immunization: a Review	Biologicals	1997	130
15	Antivenoms for the treatment of snakebite envenomings: The road ahead	Biologicals	2011	125
16	Human antibody Fc deamidation in vivo	Biologicals	2009	117
17	BVDV and innate immunity	Biologicals	2003	115
18	Immunogenicity assessment of biotherapeutic products: An overview of assays and their utility	Biologicals	2015	114
19	Monitoring influenza virus content in vaccine production: Precise assays for the quantitation of hemagglutination and neuraminidase activity	Biologicals	2008	113
20	Bovine viral diarrhoea eradication and control programmes in Europe	Biologicals	2003	112
21	Summary of recombinant human serum albumin development	Biologicals	2006	112
22	Maternal antibody blocks humoral but not T cell responses to BVDV	Biologicals	2003	110
23	Therapeutic monoclonal antibody N-glycosylation – Structure, function and therapeutic potential	Biologicals	2018	106
24	Domain III peptides from flavivirus envelope protein are useful antigens for serologic diagnosis and targets for immunization	Biologicals	2010	105
25	Bovine viral diarrhoea virus antigenic diversity: impact on disease and vaccination programmes	Biologicals	2003	104
26	Biochemical and biological characteristics of cross-reacting material 197 (CRM197), a non-toxic mutant of diphtheria toxin: Use as a conjugation protein in vaccines and other potential clinical applications	Biologicals	2011	104
27	The Development of Multi-epitope Vaccines: Epitope Identification, Vaccine Design and Clinical Evaluation	Biologicals	2001	102
28	Comparability assessments of process and product changes made during development of two different monoclonal antibodies	Biologicals	2011	100
29	A proposed protocol for the standardized preparation of PRF membranes for clinical use	Biologicals	2012	100
30	Development of novel strategies to control foot-and-mouth disease: Marker vaccines and antivirals	Biologicals	2005	98
31	The cotton rat model of respiratory viral infections	Biologicals	2009	98
32	Spiroplasmas and phytoplasmas: Microbes associated with plant hosts	Biologicals	2010	96
33	The effect of dose and strain of live attenuated measles vaccines on serological responses in young infants	Biologicals	1995	95
34	Overview of avian influenza DIVA test strategies	Biologicals	2005	91
35	Effect of constant and variable domain glycosylation on pharmacokinetics of therapeutic antibodies in mice	Biologicals	2008	90
36	Virus Assay Methods: Accuracy and Validation	Biologicals	1998	87
37	Enveloped Virus Inactivation by Caprylate: A Robust Alternative to Solvent-Detergent Treatment in Plasma Derived Intermediates	Biologicals	2002	87
38	Leptospirosis: Public health perspectives	Biologicals	2013	86
39	Changes in the Aging Immune System	Biologicals	1997	85
40	A collaborative study to establish the 1st WHO International Standard for human cytomegalovirus for nucleic acid amplification technology	Biologicals	2016	85
41	Yellow Fever Vaccines	Biologicals	1997	84
42	Optimization of 25kDa linear polyethylenimine for efficient gene delivery	Biologicals	2007	84
43	Immunology of BVDV vaccines	Biologicals	2013	84
44	Pharmacokinetics of IgG1 monoclonal antibodies produced in humanized Pichia pastoris with specific glycoforms: A comparative study with CHO produced materials	Biologicals	2011	81
45	Scrapie Removal using Planova®Virus Removal Filters	Biologicals	2001	80
46	Development of Vero Cell-Derived Inactivated Japanese Encephalitis Vaccine	Biologicals	2002	80
47	Validation of the anthrax lethal toxin neutralization assay	Biologicals	2004	80
48	Avian IgY antibodies and their recombinant equivalents in research, diagnostics and therapy	Biologicals	2012	80
49	Effect of Gamma Irradiation on Human Cortical Bone Transplants Contaminated with Enveloped and Non-enveloped Viruses	Biologicals	2002	78
50	Effective use of Gamma Irradiation for Pathogen Inactivation of Monoclonal Antibody Preparations	Biologicals	2002	78

Scientometrics

Overviews

Citing Bodies

Biologicals

Top Articles